Skip to main content

Research Resources Related to COVID-19

Date Posted Agency Name Program Name Agency Deadline Notes
04/02/2020 National Institutes of Health (NIH) Administrative Supplement 02/06/2021 NIAID
04/02/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) 04/08/2020 NIAID, NIGMS
04/02/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 02/05/2021 NIGMS
04/02/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) 10/05/2020 NHLBI
04/02/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus 03/30/2021 NIDA
04/02/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) 03/25/2021 NIAID
04/02/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) 04/25/2021 NCATS
04/02/2020 National Institutes of Health (NIH) Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) 05/13/2020 9/13/20 and others
04/02/2020 Russell Sage Foundation Social, political, economic, or psychological disruptions that affect social and living conditions in the US 05/21/2020 Deadline is for the LOI. Amount of funding: $175,000
04/02/2020 National Institutes of Health (NIH) Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed) 06/29/2020 NIAID
04/02/2020 Amazon Web Services (AWS) AWS Diagnostic Development Initiative (DDI) 06/30/2020 Up to $20M available; budget should reflect your needs
04/02/2020 National Institutes of Health (NIH) Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) 09/09/2020 NIAID/ $275,000 (direct costs)
04/02/2020 National Science Foundation (NSF) Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) $200,000 (RAPID) & supplemental funding requests. Check date with program officers
04/02/2020 Centers for Disease Control (CDC) - CGH Strengthening Global Field Epidemiology Training Program (FETP) Network 04/27/2020
04/02/2020 Centers for Disease Control (CDC) - CGH Global Health Security Partner Enhancement : Expanding Efforts to Improve Surveillance and Laboratory Data Interoperability 05/04/2020
04/02/2020 HHS- Public Health Emergency Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) 04/30/2020 Whitepapers – 4/30/20 BARDA BAA Open ONLY to COVID-19 related projects. Please see full call for Techical Descriptions and agency personnel points of contact.
04/02/2020 Centers for Disease Control - CGH Building Capacity for National Public Health Institutes 05/04/2020
04/02/2020 Kinkade Family Foundation Emergency Grant for Curators 04/12/2020
04/02/2020 National Institutes of Health (NIH) Clinic Testing Therapeutic/Indication Pairing Strategies 06/05/2020 NCATS PAR-18-332 Deadlines: June 5, October 5
04/02/2020 National Institutes of Health (NIH) Clinical Trial Planning: Therapeutic/Indication Pairing Strategies 06/16/2020 NCATS PAR 18-462 Deadlines June 16, Oct. 16
04/02/2020 National Institutes of Health (NIH) Support pre-clinical studies to evaluate a therapeutic/indication pair for drug repurposing 06/26/2020 NCATS PAR-17-465
04/02/2020 National Institutes of Health (NIH) Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease NCATS NOT-TR-20-012
04/02/2020 Wellcome Trust, Gates Foundation, Mastercard The COVID-19 Therapeutics Accelerator Up to $125 million in seed funding. The COVID-19 Therapeutics Accelerator will not be conducting a traditional funding call. To learn more about the funding process, contact epidemics@wellcome.ac.uk
04/02/2020 National Science Foundation (NSF) Ecology and Evolution of Infectious Diseases (EEID) 11/18/2020 NSF 19-592
04/03/2020 National Institutes of Health Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) 05/01/2021 NIA, NIMH
04/03/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) 06/05/2020 NCATS Other later deadlines as well
04/03/2020 National Institutes of Health (NIH) Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 06/01/2020 June 2020 anticipated deadline. Agency for Healthcare Research and Quality NOT-HS-20-008
04/06/2020 Department of Defense (DOD) Newton Award for Transformative Ideas during the COVID-19 Pandemic 05/15/2020
04/07/2020 MIT Solve Health Security and Pandemics Challenge 06/18/2020 Read terms before considering applying. https://solve.mit.edu/terms-of-service
04/07/2020 XSEDE XSEDE COVID-19 High Performance Computing Consortium Resources The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. We hope to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. Consortium members manage a range of computing capabilities that span from small clusters to some of the very largest supercomputers in the world.Researchers seeking to access the Consortium’s resources should submit a simple project proposal.
04/07/2020 Massachusetts Institute of Technology (MIT)- SOLVE SOLVE Health Security and Pandemics 06/18/2020 MIT Solve is seeking tech innovations that can slow and track the spread of an emerging outbreak, for example by improving individual hygiene, developing low-cost rapid diagnostics, analyzing data that informs decision making, and providing tools that support and protect health workers.
04/07/2020 Pullitzer Center on Crisis Reporting (PCCR) Coronavirus News Collaboration Challenge 09/30/2020 The PCCR seeks proposals that develop innovative approaches to reporting on the novel coronavirus crisis.
04/08/2020 National Endowment for the Arts NEA CARES Act 05/04/2020 This is a limited submission opportunity.
04/10/2020 Harrington Discovery Institute Harrington Scholar Award for Coronavirus 04/30/2020 In addition to dedicated drug development support and project management, awardees will receive $150k guaranteed, with the potential to receive up to $1 million in charitable support.
04/10/2020 Private Funders Fast Funding for COVID-19 Science If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant. Fast Grants are $10k to $500k and decisions are made in under 48 hours. If we approve the grant, you'll receive payment as quickly as your university can receive it.
04/10/2020 Center for Disease Control CDC Coronavirus Response Fellowship 05/01/2020 The qualified candidate should be currently pursuing or have received a bachelor's, master's or doctoral degree in one of the relevant fields. Degree must have been received within five years of the appointment start date.
04/11/2020 Mozilla COVID-19 Solutions Fund As part of the COVID-19 Solutions Fund, we will accept applications that are hardware (e.g., an open source ventilator), software (e.g., a platform that connects hospitals with people who have 3D printers who can print parts for that open source ventilator), as well as software that solves for secondary effects of COVID-19 (e.g., a browser plugin that combats COVID related misinformation). Applications will be accepted and reviewed on a rolling basis.
04/11/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) Related to HIV Comorbidities, Coinfections, and Complications within NIDDK's Mission 06/01/2020 NIDDK. NIDDK encourages the submission of applications for Competitive Revisions to active grants to address COVID-19 related research.
04/11/2020 United States Department of Defense (DOD) CDMRP PRMRP Investigator-Initiated Research Award for Emerging Viral Diseases and Respiratory Health 06/12/2020 Pre-Application due May 28
04/11/2020 United States Department of Defense (DOD) CDMRP PRMRP Technology/Therapeutic Development Award for Emerging Viral Diseases and Respiratory Health 06/12/2020 Pre-Application due May 28 The PRMRP Technology/Therapeutic Development Award is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications in one or more Focus Areas.
04/11/2020 Adira Foundation Fast-Track Grant Response: COVID-19 Rolling Deadline. Granting $50,000 total to organizations working to support the many individuals with neurodegenerative diseases and those who love and care for them during this uncertain time.
04/13/2020 United States Department of Defense (DOD) CDMRP PRMRP Clinical Trial Award for Emerging Viral Diseases and Respiratory Health 06/08/2020 Pre-Application due June 8; Sponsor deadline is June 22
04/13/2020 Open Road Alliance Charitable Grants Direct COVID-19 Response - Charitable Grant Proposals for grants and loans are accepted on a rolling basis. One-time cash need Up to $100,000 USD. Any geography and any sector, providing they can demonstrate that they are directly contributing to ‘flattening the curve’ in their community. Prioritizing clear, demonstrable, and deep impact.
04/15/2020 Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects Applications accepted on a rolling basis. $500,000
04/15/2020 Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Engagement Awards Applications accepted on a rolling basis $150,000
04/15/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus 04/15/2021 Contact your program officer.
04/15/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences 03/31/2021 OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI $200,000 (direct costs)
04/15/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) 06/26/2020 NCI, $100,000
04/15/2020 National Institutes of Health NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) 04/24/2020
04/15/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities 05/01/2021 NIMHD, NIA, NIMH $125,000 (direct costs)
04/15/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) NIEHS, multiple deadlines. Please refer to NOSI.
04/15/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 05/05/2020 NIGMS. One year of support- limited to no more than the amount of the current parent award.
04/21/2020 National Institutes of Health (NIH) NIAAA Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA 05/15/2020 $200,000 (direct costs) applications accepted until 4/15/2021
04/21/2020 National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus 05/15/2020 (applications accepted until 4/15/2021) $200,000 (direct costs)
04/21/2020 National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus 05/15/2020 Limited to no more than 25% total costs of the amount of the current parent award (applications accepted until 1/25/2022)
04/21/2020 National Institutes of Health (NIH) NIDCD Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) 06/01/2020 $125,000
04/21/2020 National Institutes of Health NIBIB Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) 06/05/2020 See individual RFAs within (other later deadlines within) Notice Number: NOT-EB-20-007
04/22/2020 American Lung Association COVID-19 and Emerging Respiratory Viruses Research Award 05/30/2020 $100,000 per year, for up to two years.
04/22/2020 Environmental Protection Agency Removal Emergency Response Program 06/10/2020 $500,000
04/22/2020 Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award Special Cycle: Supporting Engagement in and Dissemination of PCOR/CER in the Context of COVID-19 05/22/2020 $150,000
04/22/2020 Patient-Centered Outcomes Research Institute (PCORI) COVID-19 Targeted PFA 05/26/2020
04/23/2020 Department of Health and Human Services - Agency for Healthcare Research and Quality DHHS AHRQ Competitive Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) Forecast 1
04/23/2020 National Center for Complementary and Integrative Health (NCCIH) National Institute on Aging (NIA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) 10/06/2020 Applications will be accepted on a ROLLING basis through October 6, 2020 by 5:00 p.m. local time of the applicant organization. This NOSI expires on October 7, 2020. NOT-AT-20-011
04/23/2020 National Institute of Biomedical Imaging and Bioengineering (NIBIB) Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) 11/10/2020 Applications will be accepted immediately and on a ROLLING basis through November 10, 2020 by 5:00 PM local time of the applicant organization. This NOSI expires on November 10, 2020. Notice Number: NOT-EB-20-008
04/23/2020 National Institute of Environmental Health Sciences (NIEHS) Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (1) 06/01/2020 Application Due Dates for all programs: May 1, 2020; June 1, 2020; July 1, 2020; August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; February 1, 2021; March 1, 2021; April 1, 2021; May 3, 2021, by 5:00 PM local time of applicant organization. Notice Number: NOT-ES-20-015
04/23/2020 National Institute of Environmental Health Sciences (NIEHS) Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (2) 06/01/2020 Application Due Dates for all programs: May 1, 2020; June 1, 2020; July 1, 2020; August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; February 1, 2021; March 1, 2021; April 1, 2021; May 3, 2021, by 5:00 PM local time of applicant organization. This NOSI expires May 4, 2021. Notice Number: NOT-ES-20-020
04/23/2020 Issued by National Institute of Neurological Disorders and Stroke (NINDS) Notice of Special Interest regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for the Establishment and Maintenance of a Research Database for Neurological Manifestations of the SARS-CoV-2 05/08/2020 Applications are encouraged to be submitted as soon as possible and will be accepted on a rolling basis from April 6, 2020 until May 8, 2020 5:00 PM local time of applicant organization. This NOSI expires on May 9, 2020. Notice Number: NOT-NS-20-046
04/23/2020 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK 06/01/2020 Applications must be submitted by June 1, 2020, by 5pm at the local time of the applicant organization. No late revision applications will be accepted. Notice Number: NOT-DK-20-018
04/23/2020 National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed) 06/16/2020 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Funding Opportunity Announcement (FOA) Number: PA-19-237
04/23/2020 Department of Agriculture Distance Learning and Telemedicine Grants Department of Agriculture Utilities Programs 07/13/2020 Funding Opportunity Number: RUS-20-02-DLT Award Ceiling: $1,000,000 Award Floor: $50,000
04/23/2020 Department of Defense Dept. of the Army -- USAMRAA CDMRP Peer Reviewed Medical Research Program Clinical Trial Award 08/13/2020 Estimated Total Program Funding: $45,000,000 Funding Instrument Type: Cooperative Agreement Grant Clinical Trial Only Applications are not restricted to a predetermined cost limit and the maximum period of performance is 4 years.
04/27/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (1) 05/01/2021 National Institute on Aging (NIA) National Institute of Mental Health (NIMH) National Institute on Alcohol Abuse and Alcoholism ( NIAAA )- New participating organization as of 04/16/2020 for due dates on/after 04/16/2020 Notice Number: NOT-AG-20-022
04/27/2020 Merck KGaA (Germany) Research Grant for Pandemic Preparedness Applications accepted on a rolling basis
04/27/2020 Emergency Medicine Foundation (EMF) COVID-19 Research Grant 06/05/2020 The Emergency Medicine Foundation is awarding funding of up to $100,000 in new research grants on emergency medicine areas related to COVID-19. Topics may include, but are not limited to, the following: Personal Protective Equipment (PPE), including Design, Cleaning, Re-use Ventilator Scarcity Telemedicine Laboratory Testing Rapid Screening, Triage and Testing Clinical Diagnosis Epidemiology of Disease Therapeutics Diagnostic Radiology, including Point of Care Ultrasound Emergency Medicine Workforce, including Safety Emergency Physician Wellness Special Populations, such as High Risk, Homeless, Non-English Speaking, Transplantation Patients
04/27/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs 11/10/2020 National Center for Advancing Translational Sciences (NCATS) Budgets must reflect the actual needs. Applications will be accepted immediately and on a rolling basis through November 10, 2020 by 5:00 PM local time of the applicant organization.
04/27/2020 National Institutes of Health (NIH) Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) 10/05/2020 10/5/2020 (and standard R01 deadlines)** National Institute on Minority Health and Health Disparities (NIMHD) National Institute on Aging (NIA) National Institute on Drug Abuse (NIDA) National Cancer Institute (NCI)
04/27/2020 National Institutes of Health (NIH) Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) Dates may vary by awarding IC National Cancer Institute (NCI) National Center for Complementary and Integrative Health (NCCIH) National Human Genome Research Institute (NHGRI) National Institute of Allergy and Infectious Diseases (NIAID) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute of Environmental Health Sciences (NIEHS) National Institute of General Medical Sciences (NIGMS) National Institute on Minority Health and Health Disparities (NIMHD) National Institute of Biomedical Imaging and Bioengineering (NIBIB) Office of Strategic Coordination ( Common Fund ) National Center for Advancing Translational Sciences (NCATS) National Institute on Alcohol Abuse and Alcoholism (NIAAA) Funding Opportunity Number: PA-20-135
04/29/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) 06/19/2020 Office of Strategic Coordination (Common Fund) Notice Number: NOT-RM-20-015
05/01/2020 The Indo-U.S. Science and Technology Forum (IUSSTF) Call for Proposals for COVID-19 Indo-U.S. Virtual Networks 05/15/2020 $66,000
05/01/2020 The United States–India Science & Technology Endowment Fund (USISTEF) United States-India Science and Technology Endowment Fund COVID-19 Ignition Grants 05/15/2020 Ignition Stage I: $66,000 Ignition Stage II: $133,000
05/01/2020 Department of Health and Human Services Competitive Revision Supplements to Existing AHRQ Patient Centered Outcomes Research (PCOR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) 05/29/2020 Budget is contingent upon mechanism type (see RFA) Funding Opportunity Announcement (FOA) Number PA-20-072
05/01/2020 Agency for Health Care Research and Quality (AHRQ) Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement - Clinical Trial Optional) 05/29/2020 Budget is contingent upon mechanism type (see RFA) Funding Opportunity Announcement (FOA) Number PA-20-070
05/01/2020 U.S. Department of State (DOS) COVID-19 Small Grants Program 09/30/2020 $100,000
05/01/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials 10/05/2020 NHLBI Notice Number: NOT-HL-20-782
05/01/2020 National Institutes of Health Notice of Special Interest (NOSI): Data Driven Research on Coronavirus Disease 2019 (COVID-19) (R21) 06/16/2020 NLM $275,000 (direct costs)
05/01/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System 04/15/2021 $200,000 (direct costs) National Institute of Neurological Disorders and Stroke (NINDS) Notice Number: NOT-NS-20-051
05/01/2020 National Institutes of Health (NIH) Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) 04/30/2021 $275,000 (direct costs) NIAID Funding Opportunity Announcement (FOA) Number: PAR-20-177
05/01/2020 National Institutes of Health (NIH) Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) 04/30/2021 NIAID Budgets must reflect the actual needs Funding Opportunity Announcement (FOA) Number: PAR-20-178
05/01/2020 Spencer Foundation Research Grants on Education: COVID-19 Related Special Grant Cycle 05/18/2020 We will review applications received by May 4th, again on May 18th, and again on June 8th. roposed budgets for this program are limited to $50,000 total and may not include indirect cost charges per Spencer’s policy.
05/04/2020 Ministry of Defence (MoD) - United Kingdom Open Call for Innovation - COVID-19 Fast Track 05/12/2020 Defence and Security Accelerator (DASA) Applications are open to the private sector, academia, individuals and public sector research establishments. There are no nationality restrictions.
05/11/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR 11/02/2020 Notice Number: NOT-DE-20-022 National Institute of Dental and Craniofacial Research (NIDCR) Office of Research on Women's Health (ORWH) Upper $150,000USD Requests are expected not to exceed $150,000 in total direct costs; strong compelling justification is needed to exceed this cap.
05/11/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Infrastructure Access for Research on Coronavirus Disease 2019 (COVID-19) Conducted in the National Dental Practice-Based Research Network 11/02/2020 Notice Number: NOT-DE-20-023 National Institute of Dental and Craniofacial Research (NIDCR)
05/11/2020 National Institutes of Health (NIH) Notice of Additional Due Date and Additional “Areas of Focus Especially of Interest” of PAR-19-373 and PAR-19-384, "Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01)" 06/08/2020 Additional due date: March 17, 2021 Notice Number: NOT-OD-20-103 NIH Basic Behavioral and Social Science Opportunity Network (OPPNET) National Institute on Aging (NIA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute on Drug Abuse (NIDA) National Institute of Mental Health (NIMH) National Institute of Neurological Disorders and Stroke (NINDS) National Institute of Nursing Research (NINR) National Institute on Minority Health and Health Disparities (NIMHD) National Center for Complementary and Integrative Health (NCCIH) All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers. Office of Behavioral and Social Sciences Research (OBSSR)
05/11/2020 Ferring Pharmaceuticals Ferring COVID-19 Investigational Grants 10/31/2020 25,000€ Applications accepted through 10/31/2020. Applicants will be notified via email within 14 days of submission regarding the outcome of their application. Ferring is interested in funding exploratory, basic, and clinical research grants to collect data and expand knowledge about the effects of SARS-CoV-2 on reproduction, pregnancy, and foetal/neonatal health.
05/11/2020 Internet Society Foundation Emergency Response Grant Programme: COVID-19 05/17/2020 $500,000
05/11/2020 Viiv Healthcare HIV & COVID-19: RFP for Research Projects to Help Improve the Understanding and Management of COVID-19 in PLHIV 05/18/2020 250,000£
05/11/2020 Johnson & Johnson Innovation – JLABS DR-TB Lifeline Design QuickFire Challenge 05/19/2020 $50,000
05/11/2020 The Golden Goose Award 2020 Golden Goose COVID-19 Recognition 05/22/2020 Recognition and Statuette Only
05/11/2020 Booz Allen Foundation Booz Allen Foundation Innovation Grant 06/05/2020 $100,000
05/11/2020 Coalition for Epidemic Preparedness Innovations (CEPI) COVID-19 Vaccine Development and Production Unspecified 06/30/2020 Applications accepted rolling through 6/30/2020
05/11/2020 XPRIZE NEW2020 COVID-19 Call for Code Global Challenge 07/31/2020 Call for Code asks innovators to create practical, effective, and high-quality applications based on one or more IBM Cloud™ services (for example, web, mobile, data, analytics, AI, IoT, or weather) that can have an immediate and lasting impact on humanitarian issues. Teams of developers, data scientists, designers, business analysts, subject matter experts and more are challenged to build solutions to mitigate the impact of COVID-19 and climate change. $270,000
05/11/2020 National Institutes of Health (NIH) NIH Tech Accelerator Challenge 2020 06/02/2020 NIBIB, VENTUREWELL $500,000 (top prize)
05/13/2020 Draper Richards Kaplan Foundation DRK Covid-19 Urgent Response Initiative (CURI) 06/30/2020 $50,000 – $100,000 (CURI invests 25% maximum of total funding, read fine print) DRK is ready to find, fund and support the people and ideas that are tackling the most acute and time-critical social problems caused by the Covid-19 pandemic right now. We want to help jumpstart projects that can realistically deploy within 30 days. Our hope is to find 8-10 great opportunities in the next 60-90 days, to deploy capital through May, June and July.
05/13/2020 American Diabetes Association (ADA) The American Diabetes Association COVID-19 and Diabetes Research Award 05/22/2020 $100,000
05/13/2020 The Social Science Research Council (SSRC) and Henry Luce Foundation NEWRapid-Response Grants on Covid-19 and the Social Sciences 06/01/2020 Awards will range from USD$2,000 to $5,000, with the possibility of slightly more support for collaborative projects of two or more researchers.
05/13/2020 U.S. Department of State DOS DRL FY19 Countering Corruption amid COVID-19 06/12/2020 $1,000,000
05/13/2020 23andMe 23andMe Research Innovation Collaborations Program 06/12/2020 23andMe will also consider collaboration proposals focused on COVID-19. These proposals can include studies of outcomes, comorbidities, health disparities, and impacts of policies implemented to address the pandemic.
05/13/2020 The Rheumatology Research Foundation Scientist Development Award, Investigator Award & Innovative Research Award 06/01/2020 Amount varies LOI: 6/1/2020 Full application: 7/1/2020
05/13/2020 The Rheumatology Research Foundation Innovative Research Award for Community Practitioners 06/01/2020 $400,000 LOI: 6/1/2020 Full application: 8/3/2020
05/18/2020 National Institutes of Health (NIH) Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence National Cancer Institute (NCI) This Notice is being provided to allow potential applicants time to develop responsive projects and meaningful collaborations. The FOAs are expected to be published in June 2020 with expected application due dates in July 2020.
05/21/2020 Institution of Engineering and Technology (IET) E&T Innovation Awards - Small idea, Big impact: Global Challenge 07/03/2020 In response to Covid-19, we have seen many examples of innovation, including technology powered by artificial intelligence (AI) to help track the outbreak, clean hospitals, deliver supplies and develop vaccines. We've seen how big data platforms can be mobilised quickly and transparently, and be a force for good. Covid-19 has paved the way for new collaborations and out-of-the-box thinking. We would like to celebrate the innovators who have found new ways to support the government, society and individuals who need help during the coronavirus (COVID-19) outbreak.
05/21/2020 Department of Health and Human Services Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) 06/15/2020 Agency for Healthcare Research and Quality (AHRQ) Funding Opportunity Announcement (FOA) Number RFA-HS-20-003 $1,000,000
05/21/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) 09/08/2021 National Institute of Allergy and Infectious Diseases (NIAID) Notice Number: NOT-AI-20-051 First due date: 6/16/2020 Subsequent receipt dates through 9/8/2021
05/27/2020 National Institutes of Health (NIH) NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional) 09/30/2020 Department of Health and Human Services Funding Opportunity Announcement (FOA) Number: RFA-RM-20-020
05/27/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Administrative Supplements & Urgent Competitive Revisions to NCCIH Grants for Natural Product Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) & Coronavirus Disease 2019 (COVID-19) 08/18/2020 National Center for Complementary and Integrative Health (NCCIH) Office of Research on Women’s Health ( ORWH ) Notice Number: NOT-AT-20-012
05/27/2020 Robert Wood Johnson Foundation (RWJF) Emergency Response for the Health Care System 06/12/2020 Phase One - Submit a one line overview of your technology, a slide deck, and a mock up. Judges will evaluate and choose five semifinalists to move on to phase two. 6/12/2020 (Phase I) 8/18/2020 (Phase II) Can you create a digital tool supporting the health care system (including but not limited to providers, government, and public health and community organizations) during a large-scale health crisis (pandemic, natural disaster, or other public health emergency)?
05/27/2020 Robert Wood Johnson Foundation (RWJF) Emergency Response for the General Public Innovation Challenge 06/12/2020 Phase One - Submit a one line overview of your technology, a slide deck, and a mock up. Judges will evaluate and choose five semifinalists to move on to phase two. 6/12/2020 (Phase I) 8/18/2020 (Phase II) A large-scale health crisis such as the current COVID-19 pandemic, or natural disasters, can disrupt the lives of everyone in an affected community. The public faces numerous challenges during these events such as rapidly spreading misinformation, shortages of supplies like medications, and lack of access to resources and health care. Digital health tools have the capacity to support individuals during these critical periods.
05/27/2020 Pfizer, Inc. Vaccine Preventable Diseases-COVID-19 06/17/2020 Expected approximate range of grant awards: $50,000 to $250,000 USD. We will consider larger grants depending on the size and scope of the program.
05/27/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Need for Documenting 2019 Novel Coronavirus Disease (COVID-19)-Related Patient Outcomes 06/19/2020 National Institute of General Medical Sciences (NIGMS) Notice Number: NOT-GM-20-033
05/27/2020 Engineering and Physical Sciences Research Council (EPSRC) - United Kingdom Medical Robotics for Contagious Diseases Challenge 2020 09/30/2020 The prize fund is worth £15,000 (approx $18,395 USD) This seeks innovative ideas that could aid in the response to the current COVID-19 pandemic and future global pandemics. The COVID-19 pandemic offers a unique opportunity to galvanise medical robot technologies, as they play an increasingly major role in combating contagious diseases. Leading robotics research teams from across the world may apply
06/01/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Administrative Supplements to Existing NIH ECHO Cooperative Agreements (Admin Supp - Clinical Trial Not Allowed) for Coronavirus Disease 2019 (COVID-19) – related Research 06/22/2020 Office of The Director, National Institutes of Health (OD) Upper $200,000 Notice Number: NOT-OD-20-107
06/03/2020 National Institutes of Health (NIH) Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiatives 08/01/2020 The purpose of this Notice is to alert the community that NIH plans to publish four (4) Funding Opportunity Announcements (FOAs) as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative to solicit research on COVID-19 diagnostic testing in underserved and vulnerable populations. The FOAs are expected to be published in early June, and we will accept applications through August 2020 for FY20 funding.The FOAs will be Requests for Applications (RFAs) and Notices of Special Interest (NOSIs) for competitive revisions. The goal is to make awards by September 2020. Notice Number: NOT-OD-20-112
06/03/2020 National Institutes of Health (NIH) Notice of Intent to Publish a Funding Opportunity Announcement for Community Interventions to Address the Consequences of the COVID-19 Pandemic for Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) 07/01/2020 The National Institute of Minority Health and Health Disparities (NIMHD), withthe other participating NIH Institutes, Centers, andOffices(ICOs),intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit research to evaluatecommunity interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, sociocultural, behavioral, and socioeconomic consequences of the pandemic on the health of these groups. The FOA is expected to be published in June 2020 with an expected application due date in July 2020. Notice Number:NOT-MD-20-023
06/09/2020 National Institutes of Health (NIH) Notice Announcing the Availability of Common Data Elements for Research Related to the Public Health Emergency caused by Coronavirus Disease 2019 (COVID-19) National Institute of Mental Health (NIMH) Notice Number: NOT-MH-20-061 The purpose of this Notice is to extend the data-harmonization effort at the National Institute of Mental Health (NIMH) announced in NOT-MH-15-009 to research protocols pertaining to the public health emergency caused by Coronavirus Disease 2019 (COVID-19), the disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
06/09/2020 National Institutes of Health (NIH) Notice of Intent to Publish a Funding Opportunity Announcement for Digital healthcare interventions to address the secondary health effects related to social, behavioral, and economic impact of COVID-19 (R01 - Clinical Trial Optional) Estimated Publication Date of Funding Opportunity Announcement: June 20, 2020 First Estimated Application Due Date: July 20, 2020 National Institute of Mental Health (NIMH) National Eye Institute (NEI) National Institute on Aging (NIA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute of Dental and Craniofacial Research (NIDCR) National Institute on Drug Abuse (NIDA) National Institute of Nursing Research (NINR) National Center for Complementary and Integrative Health (NCCIH) Notice Number: NOT-MH-20-058
06/09/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders 10/05/2020 $ Varies (see RFAs within) Initial date 10/5/2020 (subsequent receipt dates through 9/8/2022) National Institute on Deafness and Other Communication Disorders (NIDCD) Notice Number: NOT-DC-20-008
06/09/2020 National Institutes of Health (NIH) Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional) 07/22/2020 $7,500,000 (direct costs) National Cancer Institute (NCI) National Institute of Allergy and Infectious Diseases (NIAID) Funding Opportunity Announcement (FOA) Number: RFA-CA-20-038
06/09/2020 National Institutes of Health (NIH) Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional) 07/22/2020 $2,500,000 (direct costs) National Cancer Institute (NCI) National Institute of Allergy and Infectious Diseases (NIAID) Funding Opportunity Announcement (FOA) Number: RFA-CA-20-039
06/09/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations 12/15/2020 $250,000 (direct costs) **Applications will be accepted on a rolling basis from June 10, 2020 through December 15, 2020 by 5:00 PM local time of the applicant organization.** National Institute on Minority Health and Health Disparities (NIMHD) National Eye Institute (NEI) National Heart, Lung, and Blood Institute (NHLBI) National Institute on Aging (NIA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute of Dental and Craniofacial Research (NIDCR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute on Drug Abuse (NIDA) National Institute of Environmental Health Sciences (NIEHS) National Institute of Mental Health (NIMH) National Center for Complementary and Integrative Health (NCCIH) National Center for Advancing Translational Sciences (NCATS) Notice Number: NOT-MD-20-022
06/09/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 12/15/2020 $200,000 (direct costs) **Applications will be accepted on a rolling basis from June 10, 2020 through December 15, 2020, by 5:00 PM local time of applicant organization.** National Institute of Mental Health (NIMH) National Eye Institute (NEI) National Heart, Lung, and Blood Institute (NHLBI) National Institute on Aging (NIA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute on Deafness and Other Communication Disorders (NIDCD) National Institute of Dental and Craniofacial Research (NIDCR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute on Drug Abuse (NIDA) National Institute of Nursing Research (NINR) National Institute on Minority Health and Health Disparities (NIMHD) National Center for Complementary and Integrative Health (NCCIH) National Center for Advancing Translational Sciences (NCATS) All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers. Sexual and Gender Minority Research Office (SGMRO) Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP) Office of Behavioral and Social Sciences Research (OBSSR) Office of Research on Women's Health (ORWH) Notice Number: NOT-MH-20-053
06/24/2020 National Institutes of Health (NIH) Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional) 08/07/2020 NIH intends to commit $7.5 Million in FY 2020 to fund one award. Funding Opportunity Announcement (FOA) Number: RFA-OD-20-013 Issued by Multiple offices
06/24/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations 09/08/2020 Issued by Multiple offices Notice Number: NOT-OD-20-119 Applications may be submitted beginning on July 8, 2020 for Application Due Dates of August 7, 2020 (5:00 PM local time of the applicant organization) OR September 8, 2020 (5:00 PM local time of the applicant organization).
07/01/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations 09/08/2020 Up to $700K Issued by Multiple offices Applications may be submitted beginning on July 8, 2020 Notice Number: NOT-OD-20-120
07/01/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations 08/07/2020 Up to $3.5M. Issued by Multiple offices. Notice Number: NOT-OD-20-121
07/01/2020 Department of Health and Human Services NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) 02/01/2021 National Institute on Aging (NIA) Application budgets are $NOT LIMITED$ but need to reflect the actual needs of the proposed project. Multiple Application Due Dates: July 1, 2020; August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; and February 1, 2021. Funding Opportunity Announcement (FOA) Number: PAR-20-234
07/01/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need 11/10/2020 Issued by: National Center for Advancing Translational Sciences (NCATS) Applications will be accepted immediately and on a rolling basis through November 10, 2020. Notice Number: NOT-TR-20-029
07/01/2020 Department of Health and Human Services Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) 12/01/2020 Funding Opportunity Announcement (FOA) Number: PAR-20-237 Application Due Date(s): August 28, 2020; December 1, 2020
07/01/2020 National Institutes of Health (NIH) Request for Proposals (RFP) Solicitation S20-119: Serological Sciences Network Capacity Building Centers 07/16/2020 Issued by National Cancer Institute (NCI) Notice Number: NOT-CA-20-077 Leidos Biomedical Research, Inc. (Leidos Biomed) has issued an RFP for Capacity Building Centers to support the Serological Sciences Network (SeroNet), developed to mobilize collaborative efforts to develop serological assays of high specificity and high sensitivity for deployment to test for SARS-CoV-2 induced immune responses and to rapidly expand national serological testing capacity.
07/01/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project 07/12/2021 Up to $1M. Issued by Multiple offices. Application Due Dates: July 13, 2020, November 12, 2020, March 12, 2021, and July 12, 2021. Notice Number: NOT-OD-20-129
07/01/2020 Department of Health and Human Services Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) 03/02/2021 Up to $2,250,000 (direct costs). Application Due Date(s): August 20, 2020, December 2, 2020, March 2, 2021 Funding Opportunity Announcement (FOA) Number: PAR-20-243
07/06/2020 Cisco Pandemic/COVID19 Science, Technology and Social Impact As of this posting, deadline unspecified - Rolling - Please apply ASAP. Pandemics have far reaching consequences that range from deaths to shutting down the economy as we have witnessed during the recent COVID19 crisis. Hence there is a need to be better prepared for such pandemics. We need to solve problems ranging from predictive analytics innovative devices for saving lives to technology for devising voting machines. The social and economic impact for the above areas is huge and some of the work can be transformative and save lives. RFP-20-04
07/14/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19) 08/14/2020 Applications will be accepted on a rolling basis from July 6, 2020, through August 14, 2020. Issued by National Cancer Institute (NCI) Notice Number: NOT-CA-20-082
07/14/2020 National Institutes of Health (NIH) Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) 12/16/2020 NIDDK intends to commit $5,000,000 in FY 2021 to fund 11-13 awards. Funding Opportunity Announcement (FOA) Number: RFA-DK-20-021
07/14/2020 Gilead COVID-19 RFP Program: COMMIT™ 08/03/2020 $250,000
07/14/2020 Centers for Disease Control (CDC) Improving Clinical and Public Health Outcomes through National Partnerships to Prevent and Control Emerging and Re-Emerging Infectious Disease Threats 07/31/2020 $500K Funding Opportunity Number: CDC-RFA-CK20-2003
07/14/2020 Genentech 2020 Health Equity Innovations Fund 08/10/2020 LOI: 8/10/2020 Full invited apps: 10/5/2020 $750,000
07/14/2020 Encephalitis Society Encephalitis and COVID-19 Seed Funding 08/31/2020 £10,000
07/14/2020 Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) CIPHER Grant Programme (2020/2021) 10/31/2020 $30,000
07/14/2020 Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) (1) 10/31/2020 10/31/2020 (white paper & full application) $ Negotiated after white paper stage
07/21/2020 National Institutes of Health (NIH) Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) 07/08/2021 NIAID intends to commit up to $25M for this initiative. Applications accepted on a rolling basis, beginning July 13, 2020. Funding Opportunity Announcement (FOA) Number: PAR-20-256
08/07/2020 National Institutes of Health (NIH) Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) 01/23/2021 Department of Health and Human Services Applications will be accepted on a rolling basis, beginning on August 6, 2020
09/08/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool 09/16/2020 Notice Number: NOT-OD-20-152
09/08/2020 National Institutes of Health (NIH) Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed) 09/16/2020 Funding Opportunity Announcement (FOA) Number: RFA-OD-20-014
09/08/2020 National Institutes of Health (NIH) Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed) 09/16/2020 Funding Opportunity Announcement (FOA) Number: RFA-OD-20-015
09/08/2020 National Institutes of Health (NIH) Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) 10/01/2020 Funding Opportunity Announcement (FOA) Number: RFA-OD-20-016
09/08/2020 National Institutes of Health (NIH) Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) 09/19/2020 Funding Opportunity Announcement (FOA) Number: RFA-OD-20-017
09/08/2020 National Institutes of Health (NIH) Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) 09/19/2020 Funding Opportunity Announcement (FOA) Number: RFA-OD-20-018
09/08/2020 National Institutes of Health (NIH) Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) 10/01/2020 Funding Opportunity Announcement (FOA) Number: RFA-OD-20-019
09/08/2020 National Institutes of Health (NIH) Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) 09/19/2020 Funding Opportunity Announcement (FOA) Number: RFA-OD-20-020
09/08/2020 National Institutes of Health (NIH) Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) 09/19/2020 Funding Opportunity Announcement (FOA) Number: RFA-OD-20-021
09/08/2020 National Institutes of Health (NIH) Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) 09/16/2020 Funding Opportunity Announcement (FOA) Number: RFA-OD-20-022
09/08/2020 National Institutes of Health (NIH) Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) 10/01/2020 Funding Opportunity Announcement (FOA) Number: RFA-OD-20-023
09/08/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities 05/08/2023 Notice Number: NOT-MD-20-025
09/08/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 09/01/2021 Notice Number: NOT-AI-20-065
09/28/2020 Christopher and Dana Reeve Foundation (CDRF) Quality of Life Grants Program - COVID-19 Grant 10/13/2020 13 Oct 2020 Letter of Intent - required 20 Nov 2020 Application Sponsor deadline - required
09/28/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) 07/05/2024 First Available Due Date: October 05, 2020 Notice Number: NOT-HL-20-814
11/16/2020 Centers for Disease Control Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services to Mitigate Morbidity and Mortality 01/18/2021 The purpose of this notice of funding opportunity is to understand the needs of emergency-affected and displaced populations by improving epidemiological methods, estimating morbidity and mortality of these populations during COVID-19, as well as understand the specific health sector needs of persons affected by humanitarian /public health emergencies and best practices for improving health outcomes.
11/17/2020 Centers for Disease Control and Prevention (CDC) Conducting Research to Inform Pandemic Response and Recovery of Emergency-Affected Populations by Determining Public Health Needs, Improving Methods, and Integrating Services to Mitigate Morbidity and Mortality (1) 01/18/2021 The purpose of this notice of funding opportunity is to understand the needs of emergency-affected and displaced populations by improving epidemiological methods, estimating morbidity and mortality of these populations during COVID-19, as well as understand the specific health sector needs of persons affected by humanitarian /public health emergencies and best practices for improving health outcomes.
11/24/2020 National Institutes of Health (NIH) Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities 12/30/2020 The purpose of this supplement is to provide support for successful applicants to develop partnerships with local worker centers and community organizations specifically targeting under served and disadvantaged communities with higher than average COVID-19 transmission rates.
11/24/2020 XPRIZE Foundation Pandemic Response Challenge 12/08/2020 The Pandemic Response Challenge is a challenge that focuses on the development of data-driven AI systems to predict COVID-19 infection rates and prescribe Intervention Plans (IPs) that regional governments, communities, and organizations can implement to minimize harm when reopening their economies. PHASE ONE—PREDICTOR DEVELOPMENT The goal of Phase One—Predictor Development is to provide accurate, localized predictions of COVID-19 transmission based on local data, unique intervention strategies, community resilience characteristics, and mitigation policies and practices. PHASE TWO—PRESCRIPTOR DEVELOPMENT One aim of the Pandemic Response Challenge is to foster an ecosystem that makes it easier to implement accurate and rapid prescriptions and enable ongoing improvements to the model as new interventions, treatments, and vaccinations become available. Prescriptor development encompasses the rapid creation of custom non-pharmaceutical and other intervention plan prescriptions and mitigation models to help decision-makers minimize COVID-19 infection cases while lessening economic and other negative implications of the virus.
01/04/2021 National Institutes of Health (NIH) Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research 06/01/2023 The purpose of this Notice is to outline priorities for providing supplemental funding to investigators and institutions with active National Institute of Mental Health (NIMH) awards that have been significantly impacted by the COVID-19 pandemic.
Date Posted Agency Name Title of Call Date of Call Notes
04/02/2020 Department of Energy (DOE) Invitation for COVID-19 scientific questions 03/18/2020
04/02/2020 Kaggle COVID-19 Open Research Dataset Challenge (CORD-19)
04/06/2020 National Science Foundation (NSF) Dear Colleague Letter: Open Science for Research Data 03/27/2020
04/07/2020 National Science Foundation (NSF) Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 03/25/2020 NSF 20-065
04/08/2020 National Academy of Engineering Invitation for Engineering Solutions for COVID-19 04/07/2020
04/21/2020 National Science Foundation NSF Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) 04/03/2020 NSF 20-052

COVID-19 Research Databases

Resources for Researchers

Resources for Universities

Debunking Mis/Disinformation

Congressional Activities and Resources

General Guidance on COVID-19

 Other Helpful Resources

Association of Science and Technology Centers

Date Posted Agency Name Title of Notice Date of Notice Notes
04/02/2020 SAMHSA H79SP021749: Guidance for COVID-19 Re-budgeting of Funds and Submission in eRA Commons 03/24/2020
04/02/2020 Office of Management and Budget (OMB) OMB Admin Relief for Loss of Operations due to COVID-19 03/19/2020
04/02/2020 Dept. of Health and Human Services Temporarily Repurposing Head Start and Early Head Start Centers: Partnering to Support Emergency Child Care During the COVID-19 Crisis 03/24/2020
04/02/2020 National Science Foundation (NSF) NSF Letter to Community Regarding COVID-19 (Importance Notice 146) 03/23/2020
04/02/2020 US Dept. of Energy (DOE) DOE Travel Guidance 03/10/2020
04/02/2020 US. Dept. of Justice Grantee Update #2: Guidance on Short Term Administrative Relief for Grantees Impacted by COVID-19 03/21/2020
04/02/2020 National Institutes of Health (NIH) Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) 03/10/2020
04/03/2020 Dept. of Energy PF 2020-20 COVID-19 Guidance for Financial Assistance Actions 03/30/2020
04/06/2020 National Science Foundation (NSF) Dear Colleague Letter: Open Science for Research Data (1) 03/27/2020 NSF 20-068
04/06/2020 White House UPDATE ON THE COVID-19 HIGH PERFORMANCE COMPUTING CONSORTIUM 04/06/2020 Today, U.S. Chief Technology Officer Michael Kratsios provided an update on the COVID-19 High Performance Computing Consortium, a public-private partnership between leading U.S. tech companies, universities, and federal agencies to rapidly advance coronavirus vaccine and therapeutic research by harnessing the power of supercomputers. The consortium welcomed three additional members – AMD, NVIDIA, and the National Center for Atmospheric Research’s Wyoming Supercomputing Center (NWSC) – who are contributing powerful compute resources that can be matched with researchers examining critical scientific questions related to COVID-19. Since President Trump announced the consortium on March 22, 2020, the consortium has already matched 15 research proposals with computer power and resources.
04/07/2020 Institute of Museum and Library Services (IMLS) Information for IMLS Grant Applicants and Awardees 04/07/2020 FAQs for IMLS Grant Applicants and Awardees with Questions about the Impact of COVID-19 on Their IMLS-Related Work
04/07/2020 National Institutes of Health Notice of Intent: Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19 03/26/2020 Notice Number: NOT-HS-20-007
04/10/2020 Office of Naval Research ONR Guidance: Assistance and Acquisition Related Information and Resources 04/02/2020
04/17/2020 American Society for Microbiology COVID-19 Research Registry ASM is excited to announce the launch of the COVID-19 Research Registry, a platform curated and vetted by experts in the field of virology and related disciplines to provide immediate access to top COVID-19 research.
04/17/2020 National Institutes of Health NIH Funding Guidance and Information April 13, 2020 04/13/2020
04/21/2020 Center for Disease Control New Administrative Flexibilities Guidance for CDC Recipients affected by COVID-19 04/21/2020
Last Updated: Monday, January 4, 2021 at 8:07 AM